Gastric (Stomach) Cancer Clinical Trials
35 clinical trials for Gastric (Stomach) Cancer across international registries, including 16 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma — RECRUITING · PHASE1
- Clonal Hematopoiesis Chemotherapy and Radiation Effects Study — RECRUITING
- A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma — RECRUITING · PHASE1
- Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma — RECRUITING · PHASE2
- Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria — RECRUITING
- Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial — RECRUITING · PHASE2
- An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori — RECRUITING
- Prospective Gastric Cancer Screening With Fecal Multi-target DNA Analysis — RECRUITING
- Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes — RECRUITING · NA
- An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors — RECRUITING · PHASE1
- Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma — RECRUITING · PHASE1
- Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer — RECRUITING · PHASE1
- Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma — RECRUITING
- The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial — RECRUITING · PHASE2
- A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer — RECRUITING · PHASE1
- XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC — RECRUITING · PHASE1
- ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) — ACTIVE_NOT_RECRUITING · PHASE1
- Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial — NOT_YET_RECRUITING · NA
- Fecal DNA Methylation and Helicobacter Pylori SNPs Tests for Gastric Cancer — ACTIVE_NOT_RECRUITING
- Epidemiology and Treatment of Gastric Cancer — COMPLETED
- Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes Test — NOT_YET_RECRUITING
- A Study on the Impact of Intelligent Nutrition Management on Clinical Outcomes in Chemotherapy Patients With Gastrointestinal Malignancies — ACTIVE_NOT_RECRUITING · NA
- Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer — NOT_YET_RECRUITING
- Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer — NOT_YET_RECRUITING · PHASE1
- Development of a Predictive Model for Gastric Cancer Peritoneal Metastasis and Cachexia Using BUB1 and Radiopathomics Data With Deep Learning — NOT_YET_RECRUITING
- Gastric Cancer Endoscopic Screening in an Intermediate-risk Country - ROGCAS, a Dual-centre Pilot Program — COMPLETED
- Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers — COMPLETED
- Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma — COMPLETED · PHASE2
- Comparison of Channel Esophagogastrostomy and Double Tract Reconstruction After Laparoscopic-assist Proximal Gastrectomy: A Propensity Score-Matched Analysis — COMPLETED
- Skeletal Muscle Mass Used to Assess Frailty in Older Gastric Cancer Patients — COMPLETED
- Comparing the Efficacy of Sintilimab Plus Nab-POF Regimen, Sintilimab Plus XELOX Chemotherapy, and Lenvatinib, Sintilimab Plus XELOX Chemotherapy in the Treatment of HER2-negative, Metastatic Gastric Cancer — NOT_YET_RECRUITING · PHASE2
- Advanced Gastrointestinal Endoscopic Imaging — TERMINATED · NA
- Permission to Collect Blood Over Time for Research — TERMINATED
- B-Receptor Signaling in Cardiomyopathy — COMPLETED
- Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers — WITHDRAWN
Refine this search